Your session is about to expire
← Back to Search
Mobile Health & Mindfulness for Young Adult Cancer Survivors
N/A
Recruiting
Led By David E Victorson, PhD
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
For YACS: Age at diagnosis between 18-39 years and at time of screening / study overview session
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights
Study Summary
This trial is testing four different components to see which one is the most effective in helping young adult cancer survivors improve their quality of life. The components are: e-coaching, buddy, general mindfulness training, and MVPA-specific mindfulness training.
Who is the study for?
This trial is for young adult cancer survivors aged 18-39, who are at least three months post-primary treatment but may still be on hormone therapies. They should engage in less than 60 minutes of moderate to vigorous physical activity weekly, own a smartphone with internet access, and speak English fluently. Participants need a 'Buddy' willing to support them and share Fitbit data. Pregnant individuals or those in other trials cannot join.Check my eligibility
What is being tested?
The OPT2MOVE study tests four components: e-coaching, buddy support, general mindfulness training, and MVPA-specific mindfulness training within a mobile health program aimed at increasing physical activity over 12 weeks among young adult cancer survivors to improve their quality of life.See study design
What are the potential side effects?
Since this trial focuses on exercise and mindfulness training rather than medication or invasive procedures, significant side effects are not expected. However, participants might experience typical exercise-related discomforts such as muscle soreness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I was diagnosed with my condition between the ages of 18 and 39.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Physical Activity before and after the 12-week technology supported physical activity interventions in young adult cancer survivors
Secondary outcome measures
Ability to participate in social roles and activities in young adult cancer survivors
Acceptability of the technology supported physical activity interventions as measured by a post-intervention evaluation survey
Adherence to the OPT2MOVE app + Fitbit by young adult cancer survivors
+34 moreTrial Design
16Treatment groups
Experimental Treatment
Active Control
Group I: Exp Condition 1Experimental Treatment5 Interventions
Research participant receives the Core Intervention + E-Coach + General Mindfulness Training + MVPA Specific Mindfulness Training + Buddy
Group II: Exp Condition 10Active Control2 Interventions
Research participant receives the Core Intervention + General Mindfulness Training
Group III: Exp Condition 11Active Control3 Interventions
Research participant receives the Core Intervention + MVPA Specific Mindfulness Training + Buddy
Group IV: Exp Condition 2Active Control4 Interventions
Research participant receives the Core Intervention + E-Coach + General Mindfulness Training + MVPA Specific Mindfulness Training
Group V: Exp Condition 4Active Control2 Interventions
Research participant receives the Core Intervention + E-Coach
Group VI: Exp Condition 6Active Control3 Interventions
Research participant receives the Core Intervention + E-Coach + General Mindfulness Training
Group VII: Exp Condition 7Active Control4 Interventions
Research participant receives the Core Intervention + E-Coach + MVPA Specific Mindfulness Training + Buddy
Group VIII: Exp Condition 9Active Control3 Interventions
Research participant receives the Core Intervention + General Mindfulness Training + Buddy
Group IX: Exp Condition 12Active Control2 Interventions
Research participant receives the Core Intervention + MVPA Specific Mindfulness Training
Group X: Exp Condition 14Active Control3 Interventions
Research participant receives the Core Intervention + General Mindfulness Training + MVPA Specific Mindfulness Training
Group XI: Exp Condition 15Active Control2 Interventions
Research participant receives the Core Intervention + Buddy
Group XII: Exp Condition 16Active Control1 Intervention
Research participant receives the Core Intervention
Group XIII: Exp Condition 13Active Control4 Interventions
Research participant receives the Core Intervention + General Mindfulness Training + MVPA Specific Mindfulness Training + Buddy
Group XIV: Exp Condition 3Active Control3 Interventions
Research participant receives the Core Intervention + E-Coach + Buddy
Group XV: Exp Condition 5Active Control4 Interventions
Research participant receives the Core Intervention + E-Coach + General Mindfulness Training + Buddy
Group XVI: Exp Condition 8Active Control3 Interventions
Research participant receives the Core Intervention + E-Coach + MVPA Specific Mindfulness Training
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Buddy
2017
N/A
~3290
Find a Location
Who is running the clinical trial?
National Cancer Institute (NCI)NIH
13,667 Previous Clinical Trials
40,925,828 Total Patients Enrolled
Wake Forest University Health SciencesOTHER
1,243 Previous Clinical Trials
1,004,422 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,589 Previous Clinical Trials
916,822 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I was diagnosed with cancer, other than non-melanoma skin cancer, within the last 5 years.I am willing to share my Fitbit data with the research team.I have been diagnosed with a type of skin cancer that is not melanoma.I am unable to understand and give consent for treatment.I finished my main cancer treatment over 3 months ago but may still be on hormone therapy.I am willing to partner with a Buddy if required.I am 18 years old or older.I was diagnosed with my condition between the ages of 18 and 39.I do not have any conditions that completely prevent me from exercising, do not have cancer that has spread, and am not planning any elective surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Exp Condition 10
- Group 2: Exp Condition 11
- Group 3: Exp Condition 1
- Group 4: Exp Condition 2
- Group 5: Exp Condition 4
- Group 6: Exp Condition 6
- Group 7: Exp Condition 7
- Group 8: Exp Condition 9
- Group 9: Exp Condition 12
- Group 10: Exp Condition 14
- Group 11: Exp Condition 15
- Group 12: Exp Condition 16
- Group 13: Exp Condition 13
- Group 14: Exp Condition 3
- Group 15: Exp Condition 5
- Group 16: Exp Condition 8
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical trial permit the enrollment of geriatric individuals?
"This medical experiment is enrolling patients between the ages of 18 to 39."
Answered by AI
What prerequisites are necessary to join this clinical trial?
"Eligibility for this medical study necessitates malignancies and a patient age between 18 to 39. The trial is estimated to enroll up 304 patients in total."
Answered by AI
Are there any openings available for this research project?
"According to medical databases, this clinical trial is no longer recruiting participants. Initially posted on November 1st 2022 and last edited in September 2021, the study has since been superseded by 486 other trials actively seeking patients."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger